BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 14648658)

  • 1. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
    Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
    J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
    J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
    Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
    Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
    Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
    Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of necrosis in Nigerian breast cancer.
    Ikpatt O; Ndoma-Egba R; Collan Y
    Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cathepsin-D expression in female breast cancer.
    Aaltonen M; Lipponen P; Kosma VM; Aaltomaa S; Syrjänen K
    Anticancer Res; 1995; 15(3):1033-7. PubMed ID: 7645922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.
    Younes M; Laucirica R
    Clin Cancer Res; 1997 Apr; 3(4):601-4. PubMed ID: 9815726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA; Gudlaugsson E;
    Eur J Cancer; 2007 Feb; 43(3):527-35. PubMed ID: 17110097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization.
    Günther K; Merkelbach-Bruse S; Amo-Takyi BK; Handt S; Schröder W; Tietze L
    J Pathol; 2001 Jan; 193(1):40-7. PubMed ID: 11169514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF; Ndoma-Egba R
    Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.